A Study to Evaluate the Efficacy and Safety of DEXYCU® for the Treatment of Ocular Pain Associated With Cataract Surgery

NCT05550350 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No longer pursuing indication

Conditions

Cataract

Interventions

DRUG: Dexycu
OTHER: Placebo/Vehicle

Sponsor

EyePoint Pharmaceuticals, Inc.